GR1007084B - 1,4-benzoxazine derivatives - Google Patents

1,4-benzoxazine derivatives

Info

Publication number
GR1007084B
GR1007084B GR20080100530A GR20080100530A GR1007084B GR 1007084 B GR1007084 B GR 1007084B GR 20080100530 A GR20080100530 A GR 20080100530A GR 20080100530 A GR20080100530 A GR 20080100530A GR 1007084 B GR1007084 B GR 1007084B
Authority
GR
Greece
Prior art keywords
subject
pharmaceutically acceptable
compound
administering
ester
Prior art date
Application number
GR20080100530A
Other languages
Greek (el)
Other versions
GR20080100530A (en
Inventor
Θεοδωρα Καλογεροπουλου
Ευτυχια Κοϊνη
Νικολαος Αυλωνιτης
Αλεξη Ξανθιππη
Μιχαηλ Ν. Αλεξης
Original Assignee
Ευτυχια Κοϊνη
Νικολαος Αυλωνιτης
Αλεξη Ξανθιππη
Μιχαηλ Ν. Αλεξης
Θεοδωρα Καλογεροπουλου
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ευτυχια Κοϊνη, Νικολαος Αυλωνιτης, Αλεξη Ξανθιππη, Μιχαηλ Ν. Αλεξης, Θεοδωρα Καλογεροπουλου filed Critical Ευτυχια Κοϊνη
Priority to GR20080100530A priority Critical patent/GR1007084B/en
Publication of GR20080100530A publication Critical patent/GR20080100530A/en
Publication of GR1007084B publication Critical patent/GR1007084B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/5381,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

excitotoxic brain injury, metabolic brain injury, traumatic brain injury, spinal cord injury, and for the alleviation of benign forgetfulness and the memory impairement in connention with dementia syndromes and neurodegenerative diseases, in a subject in need thereof, by administering to the subject an effective amount of a compound of the invention, or its pharmaceutically acceptable salt or ester either alone or in combination with another medication along with a pharmaceutically acceptable excipient. In another embodiment the invention provides methods for providing neuroprotection, for inhibiting cell degeneration or cell death, for treatment or prophylaxis of a neurodegenerative disease, or for preventingthe neurotoxic effect of a compound including, but not limited to, excitatory amino acids such as glutamate or toxins, in a subject in need thereof, by administering to the subject an effective amount of a compound of the invention, or its pharmaceutically acceptable salt or ester either alone or in combination with another medication along with a pharmaceutically acceptable excipient. In another embodiment the invention provides methods for the treatment of infections with the parasite Toxoplasma gondii in a subject in need thereof, by administering to the subject an effective amount of a compound of the invention, or its pharmaceutically acceptable salt or ester either alone or in combination with another medication along with a pharmaceutically acceptable excipient. A better understanding of the invention will be obtained from the following detailed description of the article and the desired features, properties, characteristics and the relation of the elements as well as the process steps, or with respect to each of the others, as set forth and exemplified in the description and illustrative embodiments.
GR20080100530A 2008-08-07 2008-08-07 1,4-benzoxazine derivatives GR1007084B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20080100530A GR1007084B (en) 2008-08-07 2008-08-07 1,4-benzoxazine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20080100530A GR1007084B (en) 2008-08-07 2008-08-07 1,4-benzoxazine derivatives

Publications (2)

Publication Number Publication Date
GR20080100530A GR20080100530A (en) 2010-03-31
GR1007084B true GR1007084B (en) 2010-11-26

Family

ID=40637180

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20080100530A GR1007084B (en) 2008-08-07 2008-08-07 1,4-benzoxazine derivatives

Country Status (1)

Country Link
GR (1) GR1007084B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1161080B (en) * 1960-12-01 1964-01-09 Geigy Ag J R Fungicidal agent
FR2714381B1 (en) * 1993-12-29 1996-02-02 Pharmascience Lab Benzoxazine derivatives, processes for obtaining them and their use as medicaments.
TW448161B (en) * 1994-07-14 2001-08-01 Otsuka Pharma Co Ltd Cyclic amide derivatives

Also Published As

Publication number Publication date
GR20080100530A (en) 2010-03-31

Similar Documents

Publication Publication Date Title
NO20084703L (en) Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
TN2015000368A1 (en) Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
UA110347C2 (en) Derivative 6-cycloalkanes 1.5 dyhidropirazol [3,4-d] pyrimidine-4-one and their use as inhibitors pde9a
HK1116073A1 (en) Bendamustine pharmaceutical compositions for lyophilisation
CA2918938C (en) Substituted aminopyrimidine compounds and methods of use
MX359207B (en) Pyrrolo[2,1-f][1,2,4]triazine compound, and preparation method and application thereof.
AU2012243329A8 (en) 5-substituted iminothiazines and their mono-and dioxides as BACE inhibitors,compositions,and their use
EA201270824A1 (en) COMPOUNDS TO REDUCE BET-AMYLOID PRODUCTS
WO2009050506A3 (en) Combination 059
WO2007002516A3 (en) Improved dosage forms for movement disorder treatment
WO2017009843A3 (en) Compositions, articles of manufacture and methods for treating cancer
TN2013000324A1 (en) 6 - cyclobutyl - 1, 5 - dihydro - pyrazolo [3, 4-d] pyrimidin- 4 - one derivatives their use as pde9a inhibitors
MY138708A (en) Biaryloxymethylarenecarboxylic acids
UA101393C2 (en) COMPOSITIONS AND USE OF TRIAZOLE DERIVATIVES FOR TREATING β-AMYLOID DISEASES AND SYNUCLEINOPATHIES
UA94036C2 (en) Bendamustine pharmaceutical compositions for lyophilisation
WO2014106800A3 (en) Substituted 2-amino pyrimidine derivatives as kinase inhibitors
WO2011107812A3 (en) Stabilized pharmaceutical composition
WO2013085849A3 (en) Sulfate esters of noribogaine
WO2008135661A3 (en) Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
GR1007084B (en) 1,4-benzoxazine derivatives
WO2012103282A3 (en) Methods and compositions for treating alzheimer's disease
CA2855719C (en) Apoaequorin for reducing neuronal injury due to ischemia
WO2015107536A3 (en) Fixed dose combination comprising linagliptin and metformin hci
WO2008036733A3 (en) Methods for treatment of vesicle transport disorders
MX2011012717A (en) DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLI C ACID AMIDES.

Legal Events

Date Code Title Description
PG Patent granted
ML Lapse due to non-payment of fees

Effective date: 20150304